• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.17% Nasdaq Up1.27%

    More On PLI.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    ProMetic Life Sciences Inc. (PLI.TO)

    -Toronto
    2.63 Down 0.01(0.38%) Apr 20
    Add to Portfolio
    ProfileGet Profile for:
    ProMetic Life Sciences Inc.
    440 Boulevard Armand-Frappier
    Suite 300
    Laval, QC H7V 4B4
    Canada - Map
    Phone: 450-781-0115
    Fax: 450-781-4477
    Website: http://www.prometic.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:197

    Business Summary 

    ProMetic Life Sciences Inc., a biopharmaceutical company, develops bio separations, plasma-derived therapeutics, and small-molecule drugs. The company offers its technologies for large-scale drug purification, drug development, proteomics, and the elimination of pathogens; and develops small molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, autoimmune disease/inflammation, and cancer. It operates in two segments, Therapeutics and Protein Technology. The Therapeutics segmentÂ’s lead product candidate is PBI-4050, which targets unmet medical needs, such as the treatment of fibrosis in patients with chronic kidney diseases and certain cancers, and the side effects associated with chemotherapy. This segment is also developing PBI-4419, an anti-fibrotic and anti-inflammatory compound for kidney injury and chronic kidney diseases; and PBI-1402 for the treatment of anemia indications. The Protein Technology segment provides plasma protein purification system, a solution for the extraction and purification of therapeutic proteins from human plasma; bioseparation products based on applications of its patented Mimetic Ligand technology for various biopharmaceutical companies; and prion capture/pathogen removal technology platform that improves the safety profile of blood products and blood-derived therapeutics. The company was formerly known as Innovon Life Sciences Holdings Limited and changed its name to ProMetic Life Sciences Inc. in May 1998. ProMetic Life Sciences Inc. was founded in 1992 and is headquartered in Laval, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on ProMetic Life Sciences Inc.

    Key Executives 
     PayExercised
    Mr. Pierre Laurin B.Sc.Pharm., M.Sc., 54
    Chief Exec. Officer, Pres and Non-Independent Director
    577.00K0.00
    Mr. Bruce Pritchard BA, CA, MloD,
    Chief Financial Officer and Chief Operating Officer
    386.00K0.00
    Mr. Patrick Sartore B.Sc., LLB,
    Gen. Counsel and Corp. Sec.
    221.00K0.00
    Dr. John Moran M.D., FRACP, FACP, FACPE, 69
    Chief Medical Officer, Independent Director and Member of Scientific Advisory Committee
    17.00K0.00
    Dr. Steven J. Burton Ph.D.,
    Chief Exec. Officer of ProMetic BioSciences Ltd
    215.00K0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.